Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI2 | P48307 | 10/20 | 0.90 |
| ▸ | PPP5C | P53041 | 2/20 | 0.71 |
| ▸ | PPP2CA | P67775 | 1/20 | 0.71 |
| ▸ | NPY4R | P50391 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | GMNN | O75496 | 1/20 | 0.61 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
| ▸ | THPO | P40225 | 1/20 | 0.61 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.50 |
| ▸ | PPM1B | O75688 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18073223 | 1.00 | TFPI2 (0.90) | TFPI2PPP5CPPP2CANPY4RLMNA | |
| SCHEMBL9880174 | 1.00 | TFPI2 (0.90) | TFPI2PPP5CPPP2CANPY4RLMNA | |
| SCHEMBL13311599 | 0.98 | TFPI2 (0.93) | TFPI2PPP5CPPP2CANPY4RLMNA | |
| SCHEMBL2332631 | 0.86 | TFPI2 (0.77) | TFPI2PPP5CPPP2CANPY4RLMNA | |
| SCHEMBL9880167 | 0.84 | TFPI2 (0.75) | TFPI2PPP5CPPP2CANPY4RLMNA | |
| SCHEMBL13311565 | 0.84 | TFPI2 (0.75) | TFPI2PPP5CPPP2CANPY4RLMNA | |
| SCHEMBL12122108 | 0.84 | TFPI2 (0.65) | TFPI2PPP5CPPP2CANPY4RLMNA | |
| SCHEMBL9880150 | 0.83 | TFPI2 (0.73) | TFPI2PPP5CPPP2CANPY4RLMNA | |
| SCHEMBL2334396 | 0.83 | TFPI2 (0.73) | TFPI2PPP5CPPP2CANPY4RLMNA | |
| Lb-100 SCHEMBL9880148 | 0.83 | TFPI2 (1.00) | TFPI2PPP5CPPP2CANPY4RLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100137294-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS | GENETIC TECHNOLOGIES LIMITED (AU) | 2010-06-03 | — | — | US | disclosed |
| US-20100137294-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS | GENETIC TECHNOLOGIES LIMITED (AU) | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137294-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS | PPP1R10, TASP1, PPP5C | TFPI2 1086/4885PPP5C 3/4885PPP2CA 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.